U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Jane Street Group LLC

Jane Street Group LLC reduced its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 25.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,918 shares of the company's stock after selling 8,849 shares during the period. Jane Street Group LLC owned 0.17% of U.S. Physical Therapy worth $2,193,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Southernsun Asset Management LLC grew its stake in shares of U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock worth $46,302,000 after buying an additional 52,062 shares in the last quarter. State Street Corp lifted its holdings in shares of U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock valued at $56,522,000 after acquiring an additional 99,244 shares during the last quarter. Stifel Financial Corp grew its position in U.S. Physical Therapy by 12.1% in the third quarter. Stifel Financial Corp now owns 57,166 shares of the company's stock worth $4,838,000 after acquiring an additional 6,154 shares in the last quarter. HighTower Advisors LLC increased its stake in U.S. Physical Therapy by 13.6% during the third quarter. HighTower Advisors LLC now owns 4,714 shares of the company's stock worth $399,000 after acquiring an additional 566 shares during the last quarter. Finally, Centiva Capital LP raised its position in U.S. Physical Therapy by 42.4% during the third quarter. Centiva Capital LP now owns 4,941 shares of the company's stock valued at $418,000 after purchasing an additional 1,470 shares during the period.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on USPH. Barrington Research reiterated an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Citizens Jmp upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. JMP Securities started coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an "outperform" rating and a $113.00 price target for the company. JPMorgan Chase & Co. boosted their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research report on Tuesday, December 3rd. Finally, Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their price target for the stock from $100.00 to $115.00 in a report on Monday, December 16th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of "Buy" and an average target price of $114.00.

Insider Activity

In related news, COO Graham D. Reeve sold 1,724 shares of the company's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $96.29, for a total transaction of $166,003.96. Following the transaction, the chief operating officer now directly owns 7,106 shares of the company's stock, valued at $684,236.74. This represents a 19.52 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Nancy Ham sold 1,172 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the transaction, the director now directly owns 1,112 shares of the company's stock, valued at $107,552.64. This represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,412 shares of company stock worth $706,605. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Trading Up 0.5 %

USPH stock traded up $0.42 during mid-day trading on Tuesday, reaching $90.26. The company had a trading volume of 42,327 shares, compared to its average volume of 94,385. The company has a market capitalization of $1.36 billion, a PE ratio of 96.02, a price-to-earnings-growth ratio of 4.23 and a beta of 1.46. The firm has a 50 day moving average of $91.12 and a 200 day moving average of $89.56. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy's dividend payout ratio (DPR) is 187.23%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.